Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Presse Med ; 31(28): 1329-34, 2002 Sep 07.
Artigo em Francês | MEDLINE | ID: mdl-12355996

RESUMO

DEFINITION: Blackwater fever is a clinical entity characterized by acute intravascular hemolysis classically occuring after the re-introduction of quinine in long-term residents in Plasmodium falciparum endemic areas and repeatedly using the product. CLINICAL PROFILE: The symptomatology appears brutally with emission of porto-colored urine, icterus, pallor, nausea, fever and acute renal failure. The hemolytic-like anemia is immediately severe. Parasitemia is mild or absent. The mechanism of renal failure is tubular necrosis. QUININE AND SIMILAR MOLECULES: Well known at the start of the 20th century, blackwater fever has become exceptional since 1950, when quinine was replaced by chloroquine. The disease reappeared in 1990, following the re-utilization of quinine because of resistance to chloroquine. Thereafter, several cases have been described with halofantrine and mefloquine, two new molecules similar to quinine (amino-alcohol family). The physiopathogenesis of the disease is not well known, however it would appear that the concomitance of a double sensitivization of the red blood cells to the P. falciparum red blood cells and to the amino-alcohols is necessary to provoke the hemolysis. EVOLUTION: The severity of the clinical picture often requires initial management in intensive care unit. Nowadays, however, prognosis is good and the disease usually regresses without after effects.


Assuntos
Febre Hemoglobinúrica , Adolescente , Adulto , Idoso , Antimaláricos/efeitos adversos , Antimaláricos/uso terapêutico , Atovaquona , Febre Hemoglobinúrica/induzido quimicamente , Febre Hemoglobinúrica/diagnóstico , Febre Hemoglobinúrica/mortalidade , Febre Hemoglobinúrica/fisiopatologia , Febre Hemoglobinúrica/terapia , Cuidados Críticos , Diagnóstico Diferencial , Combinação de Medicamentos , Humanos , Mefloquina/efeitos adversos , Pessoa de Meia-Idade , Naftoquinonas/uso terapêutico , Fenantrenos/efeitos adversos , Prognóstico , Proguanil/uso terapêutico , Pirimetamina/uso terapêutico , Quinina/efeitos adversos , Sulfadoxina/uso terapêutico
3.
Clin Infect Dis ; 32(8): 1133-40, 2001 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-11283802

RESUMO

Blackwater fever (BWF) is a severe clinical syndrome, characterized by intravascular hemolysis, hemoglobinuria, and acute renal failure that is classically seen in European expatriates chronically exposed to Plasmodium falciparum and irregularly taking quinine. BWF virtually disappeared after 1950, when chloroquine superseded quinine. We report 21 cases of BWF seen in France from 1990 through 1999 in European expatriates who lived in sub-Saharan Africa. All patients had macroscopic hemoglobinuria, jaundice, and anemia. Acute renal failure occurred in 15 patients (71%), 7 of whom required dialysis. The presumed triggers of BWF were halofantrine (38%), quinine (24%), mefloquine (24%), and halofantrine or quinine (14%). Glucose-6-phosphate dehydrogenase (G6PD) activity was normal in the 14 patients who underwent this test. Low-level P. falciparum parasitemia was found in 8 patients. All 21 patients survived. Our data and 13 cases reported in the literature suggest a resurgence of classic BWF among Europeans living in Africa and a need to discuss attendant therapeutic implications.


Assuntos
Febre Hemoglobinúrica/epidemiologia , Adolescente , Adulto , África , Idoso , Febre Hemoglobinúrica/complicações , Febre Hemoglobinúrica/tratamento farmacológico , Febre Hemoglobinúrica/fisiopatologia , Europa (Continente) , Feminino , França/epidemiologia , Humanos , Masculino , Pessoa de Meia-Idade , Admissão do Paciente , Fatores de Tempo , Resultado do Tratamento
4.
Clin Infect Dis ; 23(6): 1274-81, 1996 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8953071

RESUMO

We prospectively studied 50 Vietnamese patients with blackwater fever (BWF). All patients had fever and hemoglobinuria, 40 (80%) were jaundiced, 25 (50%) had hepatomegaly, 15 (34%) had splenomegaly, and 9 (18%) had hepatosplenomegaly. Twenty-one patients (42%) had impaired renal function, with creatinine clearances of < 50 mL/min/m2; however, only four (8%) developed oliguric renal failure, three (6%) of whom required dialysis. Forty-four patients (88%) developed anemia, which was severe (hematocrit, < 20% in 32 (64%). One patient died, representing a death rate for this once-feared disease that is considerably lower than that reported by earlier investigators. BWF was associated with quinine ingestion in 28 patients (56%), glucose-6-phosphate dehydrogenase (G6PD) deficiency in 27 (54%), and concurrent malaria infection in 16 (32%). There was no statistically significant difference in the severity of BWF associated with each of these three factors, as assessed by creatinine clearance and the hematocrit value on admission and by the number of units of blood transfused. There was considerable overlap in the occurrence of G6PD deficiency, quinine ingestion, and malaria, suggesting that these factors may interact and that it may not be justifiable to regard hemoglobinuria caused by G6PD deficiency as a separate syndrome.


Assuntos
Febre Hemoglobinúrica/fisiopatologia , Febre Hemoglobinúrica/epidemiologia , Feminino , Humanos , Masculino , Estudos Prospectivos , Vietnã/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...